Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer
Dongbing DingThird Affiliated Hospital of Sun Yat-sen UniversityRongpu LiangDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaTan LiThird Affiliated Hospital of Sun Yat-sen UniversityTianyun LanThird Affiliated Hospital of Sun Yat-sen UniversityYiquan LiDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaShengxin HuangDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaGuanhui HeThird Affiliated Hospital of Sun Yat-sen UniversityJiannan RenDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaWeibo LiThird Affiliated Hospital of Sun Yat-sen UniversityZongheng ZhengThird Affiliated Hospital of Sun Yat-sen UniversityTufeng ChenSun Yat-sen UniversityJiafeng FangDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaLijun HuangDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaXintao ShuaiNanomedicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Electronic address: [email protected]Bo WeiDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. Electronic address: [email protected]
2024en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba